BACKGROUND: Brain arteriovenous malformations (BAVM) are high-flow vascular lesions prone to intracranial hemorrhage (ICH). Abnormal angiogenesis is a key characteristic of BAVM tissue. Angiopoietin-like 4 (ANGPTL4), a secreted glycoprotein, is thought to be involved in angiogenesis and required for proper postnatal blood vessel partitioning. We investigated whether common single nucleotide polymorphisms (SNPs) in ANGPTL4 were associated with risk of BAVM or ICH. METHODS AND RESULTS: We conducted a case-control study of 216 Caucasian BAVM cases and 246 healthy controls, and a secondary case-only analysis, comparing 83 ruptured (ICH) with 133 unruptured BAVM cases at presentation. Four tagSNPs in ANGPTL4 captured variation over a 10-kb region (rs2278236, rs1044250, rs11672433, and rs1808536) and were tested for association with BAVM or ICH. The minor allele (A) of rs11672433 (exon 6, Pro389Pro) was associated with an increased risk of BAVM (p = 0.006), which persisted after adjusting for multiple comparisons (p = 0.03). After adjustments for age and sex, carriers of the minor allele (A) remained at higher risk for BAVM compared to noncarriers (odds ratio, OR = 1.56; 95% confidence interval, CI = 1.01-2.41; p = 0.046) and risk of BAVM was increased with increasing copy of the minor A allele (OR = 1.49, 95% CI = 1.03-2.15; p(trend) = 0.03). Five common haplotypes (frequency >1%) were inferred; overall haplotype distribution differed between BAVM cases and controls (χ(2) = 12.2, d.f. = 4, p = 0.02). Neither SNPs (p > 0.05) nor haplotype distribution (χ(2) = 1.1, d.f. = 4, p = 0.89) were associated with risk of ICH among BAVM cases. CONCLUSION: A synonymous SNP in ANGPTL4 and haplotypes carrying it are associated with risk of BAVM but not with ICH presentation in BAVM cases.
BACKGROUND:Brain arteriovenous malformations (BAVM) are high-flow vascular lesions prone to intracranial hemorrhage (ICH). Abnormal angiogenesis is a key characteristic of BAVM tissue. Angiopoietin-like 4 (ANGPTL4), a secreted glycoprotein, is thought to be involved in angiogenesis and required for proper postnatal blood vessel partitioning. We investigated whether common single nucleotide polymorphisms (SNPs) in ANGPTL4 were associated with risk of BAVM or ICH. METHODS AND RESULTS: We conducted a case-control study of 216 Caucasian BAVM cases and 246 healthy controls, and a secondary case-only analysis, comparing 83 ruptured (ICH) with 133 unruptured BAVM cases at presentation. Four tagSNPs in ANGPTL4 captured variation over a 10-kb region (rs2278236, rs1044250, rs11672433, and rs1808536) and were tested for association with BAVM or ICH. The minor allele (A) of rs11672433 (exon 6, Pro389Pro) was associated with an increased risk of BAVM (p = 0.006), which persisted after adjusting for multiple comparisons (p = 0.03). After adjustments for age and sex, carriers of the minor allele (A) remained at higher risk for BAVM compared to noncarriers (odds ratio, OR = 1.56; 95% confidence interval, CI = 1.01-2.41; p = 0.046) and risk of BAVM was increased with increasing copy of the minor A allele (OR = 1.49, 95% CI = 1.03-2.15; p(trend) = 0.03). Five common haplotypes (frequency >1%) were inferred; overall haplotype distribution differed between BAVM cases and controls (χ(2) = 12.2, d.f. = 4, p = 0.02). Neither SNPs (p > 0.05) nor haplotype distribution (χ(2) = 1.1, d.f. = 4, p = 0.89) were associated with risk of ICH among BAVM cases. CONCLUSION: A synonymous SNP in ANGPTL4 and haplotypes carrying it are associated with risk of BAVM but not with ICH presentation in BAVM cases.
Authors: Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler Journal: Nat Genet Date: 2005-10-23 Impact factor: 38.330
Authors: Achal S Achrol; Ludmila Pawlikowska; Charles E McCulloch; K Y Trudy Poon; Connie Ha; Jonathan G Zaroff; S Claiborne Johnston; Chanhung Lee; Michael T Lawton; Stephen Sidney; Douglas A Marchuk; Pui-Yan Kwok; William L Young Journal: Stroke Date: 2005-12-01 Impact factor: 7.914
Authors: Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young Journal: Ann Neurol Date: 2006-01 Impact factor: 10.422
Authors: Ludmila Pawlikowska; Mary N Tran; Achal S Achrol; Connie Ha; Esteban Burchard; Shweta Choudhry; Jonathan Zaroff; Michael T Lawton; Richard Castro; Charles E McCulloch; Douglas Marchuk; Pui-Yan Kwok; William L Young Journal: Stroke Date: 2005-09-22 Impact factor: 7.914
Authors: Tomoki Hashimoto; Yongqin Wu; Michael T Lawton; Guo-Yuan Yang; Nicholas M Barbaro; William L Young Journal: Neurosurgery Date: 2005-05 Impact factor: 4.654
Authors: Olga Gealekman; Alison Burkart; My Chouinard; Sarah M Nicoloro; Juerg Straubhaar; Silvia Corvera Journal: Am J Physiol Endocrinol Metab Date: 2008-08-26 Impact factor: 4.310
Authors: Shantel Weinsheimer; Ari D Brettman; Ludmila Pawlikowska; D Christine Wu; Michael R Mancuso; Frank Kuhnert; Michael T Lawton; Stephen Sidney; Jonathan G Zaroff; Charles E McCulloch; William L Young; Calvin Kuo; Helen Kim Journal: Transl Stroke Res Date: 2012-08-14 Impact factor: 6.829
Authors: Nasrine Bendjilali; Helen Kim; Shantel Weinsheimer; Diana E Guo; Pui-Yan Kwok; Jonathan G Zaroff; Stephen Sidney; Michael T Lawton; Charles E McCulloch; Bobby P C Koeleman; Catharina J M Klijn; William L Young; Ludmila Pawlikowska Journal: PLoS One Date: 2013-10-03 Impact factor: 3.240
Authors: Ludmila Pawlikowska; Jeffrey Nelson; Diana E Guo; Charles E McCulloch; Michael T Lawton; Helen Kim; Marie E Faughnan Journal: Mol Genet Genomic Med Date: 2018-03-06 Impact factor: 2.183
Authors: Eun-Jung Choi; Espen J Walker; Fanxia Shen; S Paul Oh; Helen M Arthur; William L Young; Hua Su Journal: Cerebrovasc Dis Date: 2012-05-09 Impact factor: 2.762